Sinus Dilation Market is expected to reach US$ 3,859.75 million by 2027

Sinus Dilation Market: Key Insights

According to our new research study on “Sinus Dilation Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Product, Procedure Type, End User, and Geography,” the global sinus dilation market size is expected to reach US$ 3,859.75 million by 2027 from US$ 1,918.73 million in 2019; it is estimated to grow at a CAGR of 9.3% during 2019–2027. The report highlights trends prevailing in the market and factors driving its growth. The sinus dilation market growth is attributed owing to growing need for surgical procedures to treat sinusitis, growing benefits of balloon sinuplasty/sinus dilation over conventional sinus surgeries, prevalence of favorable reimbursement policies. However, the high cost of sinus dilation procedure may hinder the market growth.

North America held the largest market share in the sinus dilation industry, with the US holding the largest market share, followed by Canada and Mexico. The market for sinus dilation in the US is expected to grow rapidly owing to growing prevalence of chronic sinusitis, development of new devices and technologies such as balloon sinus dilation systems and the higher adoption of these devices and increased patient awareness about sinus surgical procedures. According to the statistics reported by CDC in 2013, 29 million people in the US were suffering from chronic sinusitis, which has been listed as one of the 10 most expensive physical health disorders. The demand for rapid treatment offered by new sinus dilation systems is expected to offer significant opportunities in the US market during the forecast period. For instance, the US-based medical device company named Medtronic offers a wide range of sinus-focused products, which can help treat people suffering from sinus disease. According to the Center of Disease Control and Prevention (CDC), around 12% of the population in the age group of 18 years and above in the US is suffering from sinusitis. The increasing rate of chronic sinusitis is expected to provide high growth opportunities for the sinus dilation market in the US. In addition, according to the National Health and Nutrition Examination Survey 2018, about 14.8 million adults have at least one sinonasal symptom and about 2.37 million adults suffer from two or more cardinal symptoms from chronic rhinosinusitis in the US.

Growing Need for Surgical Procedures to Treat Sinusitis Fuel Sinus Dilation Market Growth

According to the National Health Interview Survey for 2018, 11.2% of people are affected by sinusitis in the US. Similarly, according to the American Laryngological, Rhinological, and Otological Society, Inc.’s data for 2019, the number of surgeries conducted to treat sinusitis increased to 18,164 in 2016 from 15,509 in 2012. Also, the number of balloon procedures performed increased to 25,640 in 2016 from 5,603 in 2012. Thus, the increasing number indicates that balloon sinuplasty is preferred among the patients as it has shown improved outcomes. Rising environmental concerns, such as climatic changes and pollution, are responsible for the growing number of chronic sinusitis cases. Additionally, lifestyle changes are contributing to the rising incidences of sinusitis. For instance, it is estimated that more than 135 million people in India have chronic sinusitis. Likewise, the incidences of sinus cancer in Germany are increasing. According to the data of the Munich Cancer Registry published in January 2020, there were 724 diagnosed sinuses cancer cases from 1998 to 2018. With these growing cases of sinusitis, surgical procedures are also increasing. Thus, this rising demand for surgical procedures is leading the sinus dilation market growth.

Sinus Dilation Market: Segmental Overview

Product-Based Insights

The global sinus dilation market, based on product, is segmented into endoscopes, balloon sinus dilation devices, sinus stents/implants, and handheld instruments. The balloon sinus dilation devices held the largest share in 2019. However, the sinus stents/implants segment is expected to witness the highest growth from 2019 to 2027.

Procedure Type -Based Insights

The global sinus dilation market, based on procedure type, is bifurcated into standalone sinus dilation procedures and hybrid sinus dilation procedures. The standalone sinus dilation procedures held a larger share in 2019. Standalone balloon dilation has proven to be an effective and beneficial alternative to the standard functional endoscopic sinus surgery for patients with certain types of chronic sinusitis that have failed conservative medical antibiotic management. Some of the advantages are reduction of symptoms, reduction of episodes of infectious sinusitis, and need for surgical revision at one year. However, the hybrid sinus dilation procedures segment is expected to witness a higher growth from 2019 to 2027.

End User-Based Insights

The global sinus dilation market, based on end user, is segmented into hospitals, ambulatory surgical centers, and ENT clinics. The hospitals segment held the largest share in 2019 and is expected to witness lucrative growth from 2019 to 2027.

Sinus Dilation Market: Competitive Landscape and Key Developments

Medtronic; Smith & Nephew; Johnson and Johnson Services, Inc.; Stryker Corporation; Intersect ENT, Inc.; Dalent Medical; InnAccel Technologies Pvt Ltd.; Olympus Corporation; SinuSys Corporation; and AED.MD are among the leading companies in the sinus dilation market. The sinus dilation market share is anticipated to flourish with the development of new innovative products by market players.

• In May 2020, Smith & Nephew entered into a partnership with Fiagon AG Medical Technologies (Fiagon) to distribute its ENT surgical navigation portfolio in Asia Pacific. This partnership agreement includes markets such as China, India, Australia, New Zealand, and ASEAN.
• In April 2018, Intersect ENT, Inc. launched its SINUVA (mometasone furoate) sinus implant for the US market. The product treats recurrent nasal polyps’ disease in patients previously operated on ethmoid sinus surgery.